SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study
Abstract Background: Type 2 diabetes mellitus (T2DM) is a progressive chronic disease associated with severe microvascular and macrovascular complications. Our aim is to assess the real world effectiveness of SGT" inhibitors in achieving metabolic therapeutic goals. Methods: A retrospective, ob...
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
2017
|
| Acceso en línea: | http://eprints.uanl.mx/17587/1/372.pdf |